# Study to Compare the Pharmacokinetics of IV Diclofenac Sodium (2 Doses)Versus Oral Diclofenac Potassium

> **NCT00474136** · PHASE1 · COMPLETED · sponsor: **Javelin Pharmaceuticals** · enrollment: 36 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Intravenous diclofenac sodium (DIC075V) 18.75 mg
- **DRUG:** Intravenous diclofenac sodium (DIC075V) 37.5 mg
- **DRUG:** Oral diclofenac potassium 50 mg

## Key facts

- **NCT ID:** NCT00474136
- **Lead sponsor:** Javelin Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-03
- **Primary completion:** 2007-05
- **Final completion:** 2007-05
- **Target enrollment:** 36 (ACTUAL)
- **Last updated:** 2008-01-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00474136

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00474136, "Study to Compare the Pharmacokinetics of IV Diclofenac Sodium (2 Doses)Versus Oral Diclofenac Potassium". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT00474136. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*